z-logo
open-access-imgOpen Access
Immune Suppression in Pregnancy and Cancer: Parallels and Insights
Author(s) -
Irina Kareva
Publication year - 2020
Publication title -
translational oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.343
H-Index - 52
eISSN - 1944-7124
pISSN - 1936-5233
DOI - 10.1016/j.tranon.2020.100759
Subject(s) - immune system , immunity , fetus , immunology , pregnancy , effector , cancer , disease , homeostasis , biology , medicine , pathology , microbiology and biotechnology , genetics
Immune system has evolved to maintain homeostatic balance between effector and regulatory immunity, which is critical to both elicit an adequate protective response to fight pathogens and disease, such as cancer, and to prevent damage to healthy tissues. Transient immune suppression can occur under normal physiological conditions, such as during wound healing to enable repair of normal tissue, or for more extended periods of time during fetal development, where the balance is shifted towards regulatory immunity to prevent fetal rejection. Interestingly, tumors can exhibit patterns of immune suppression very similar to those observed during fetal development. Here some of the key aspects of normal patterns of immune suppression during pregnancy are reviewed, followed by a discussion of parallels that exist with tumor-related immune suppression and consequent potential therapeutic implications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom